Summary
This report provides
comprehensive information on the therapeutic development for Kidney Disease,
complete with comparative analysis at various stages, therapeutics assessment by
drug target, mechanism of action (MoA), route of administration (RoA) and
molecule type, along with latest updates, and featured news and press releases.
It also reviews key players involved in the therapeutic development for Kidney
Disease and special features on late-stage and discontinued projects.
Global Markets Direct’s
report features investigational drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is built using data and
information sourced from Global Markets Direct’s proprietary databases,
Company/University websites, SEC filings, investor presentations and featured
press releases from company/university sites and industry-specific third party
sources, put together by Global Markets Direct’s team. Drug profiles/records
featured in the report undergoes periodic updation following a stringent set of
processes that ensures that all the profiles are updated with the latest set of
information. Additionally, processes including live news & deals tracking,
browser based alert-box and clinical trials registries tracking ensure that the
most recent developments are captured on a real time basis.
The report enhances decision
making capabilities and help to create effective counter strategies to gain
competitive advantage. It strengthens R&D pipelines by identifying new targets
and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in
the report may be removed or altered based on the availability and relevance of
data for the indicated disease.
Scope
-
The report provides a
snapshot of the global therapeutic landscape of Kidney Disease
-
The report reviews key
pipeline products under drug profile section which includes, product
description, MoA and R&D brief, licensing and collaboration details & other
developmental activities
-
The report reviews key
players involved in the therapeutics development for Kidney Disease and
enlists all their major and minor projects
-
The report summarizes all
the dormant and discontinued pipeline projects
-
A review of the Kidney
Disease products under development by companies and universities/research
institutes based on information derived from company and industry-specific
sources
-
Pipeline products coverage
based on various stages of development ranging from pre-registration till
discovery and undisclosed stages
-
A detailed assessment of
monotherapy and combination therapy pipeline projects
-
Coverage of the Kidney
Disease pipeline on the basis of target, MoA, route of administration and
molecule type
-
Latest news and deals
relating related to pipeline products
Reasons to buy
-
Provides strategically
significant competitor information, analysis, and insights to formulate
effective R&D development strategies
-
Identify emerging players
with potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage
-
Develop strategic
initiatives by understanding the focus areas of leading companies
-
Identify and understand
important and diverse types of therapeutics under development for Kidney
Disease
-
Plan mergers and
acquisitions effectively by identifying key players of the most promising
pipeline
-
Devise corrective measures
for pipeline projects by understanding Kidney Disease pipeline depth and focus
of Indication therapeutics
-
Develop and design
in-licensing and out-licensing strategies by identifying prospective partners
with the most attractive projects to enhance and expand business potential and
Scope
-
Modify the therapeutic
portfolio by identifying discontinued projects and understanding the factors
that drove them from pipeline
For More Related
Market Research Reports click here:
